Skip to main content


Our Commitment to Transparency

Our Commitment to Transparency

Janssen recognises that partnerships with healthcare professionals, patients, patient organisations, the health service, policy makers and academia play an important part in developing the most effective therapeutic solutions for unmet medical needs. To ensure successful partnerships, Janssen is fully dedicated to working with all stakeholders based on a partnership of trust and transparency. Our policy is to adhere to strict codes of conduct and internal auditing systems in order to ensure that as a company we are compliant with relevant legal and regulatory requirements.

Public disclosure of payments to Healthcare Professionals and Healthcare Organisations

Janssen EMEA clinical research

At Janssen, our core ambition is to bring innovative treatments to patients who need them. Today’s medical challenges are far more complex than ever before. That’s why we never limit the search for new medicines to our own four walls. We look at the world as our lab, seeking innovative ideas wherever they occur. We believe in connecting our own expertise and capabilities with those of others, seeking the most creative minds in every field. Together, we can solve problems and find transformational solutions. At Janssen, we collaborate with the world for the health of everyone in it.

Yet it’s not just about finding new treatments. We look at these medical challenges in a broader context. We go beyond the medicine – ensuring people have the information, education and support to access the treatments they need and use them correctly for the best possible results. Helping people live full and happy lives inspires us.

Collaborating with healthcare professionals and organisations is essential to achieving this ambition. We regularly work with healthcare professionals and healthcare organisations, for example inviting them to speak at medical educational events or seeking their advice and expertise on our services to patients and the healthcare community. Individuals may sometimes be compensated for providing these services to the industry and these payments are referred to as Transfers of Value. Transfer of Value can also include sponsoring an individual to attend an important medical congress by meeting their registration and reasonable travel and accommodation costs. Organisations may be provided with funding to help with education for healthcare professionals.
Janssen are proud of the relationships and collaborations we have with Healthcare Organisations and HealthCare Professionals and we are encouraging all of our healthcare partners to join us in being fully transparent in disclosing the details of any payments we have made to them on an individual basis.
The requirement to disclose Transfers of Value is part of the industry (Irish Pharmaceutical Healthcare Association) code of practice and the information on all Janssen Transfer of Value payments will be disclosed on the IPHA website from 1st July 2016. Further information about the disclosure of these payments can be found on the IPHA website

If you are an Irish healthcare professional or healthcare organisation, further information can be found at:

At Janssen, we are committed to improving transparency in everything we do and wholeheartedly embrace a transparent approach to our partnerships with the healthcare professionals and organisations we work with.